Manganese Ion‐Based NanoPlatforms for Tumor Theranostics
Advanced Healthcare Materials · 2026-09 · 15 (33)
DOI: 10.1002/adhm.71519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.08.2026. Verfasst von Xiangzhou Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beiji…. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Neoplasms, Manganese, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Strategic Priority Research Program of the Chinese Academy of Sciences.
Abstract (Originalsprache)
Manganese‐ion‐based nanoparticles have emerged as highly versatile platforms that seamlessly integrate diagnostic and therapeutic functions, enabling precision cancer theranostics. In this review, we discuss manganese‐based nanomaterials through a design‐oriented framework that connects synthesis, structure, function, application, and limitation. Mainstream preparation strategies, including thermal decomposition, permanganate reduction, hydrothermal/solvothermal synthesis, template‐assisted construction, coprecipitation, and mild biomimetic routes, are compared with respect to physicochemical control, Mn activation behavior, scalability, and biomedical suitability. The diagnostic applications of manganese‐based nanoplatforms are discussed, including activatable T 1 ‐weighted magnetic resonance imaging (MRI) and multimodal imaging systems, as well as Mn‐activated DNAzyme platforms for gene regulation. We further review therapeutic modalities enabled by Mn 2 + , encompassing chemodynamic therapy (CDT), nanozyme‐mediated redox regulation within the tumor microenvironment, stimulus‐responsive drug and prodrug delivery, magnetic hyperthermia, and their synergistic combinations. Finally, we critically analyze key biosafety considerations along with current translational challenges and future perspectives for developing clinically viable, image‐guided combination cancer therapies based on manganese‐ion nanoplatforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Hanyong Peng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Youth Fund from National Natural Science Foundation of China
Zitieren
APA
Li, X., Xie, W., Jin, X., Sun, T., Shang, Y., Deng, Z., & Peng, H. (2026). Manganese Ion‐Based NanoPlatforms for Tumor Theranostics. Advanced Healthcare Materials, 15(33). https://doi.org/10.1002/adhm.71519
Vancouver
Li X, Xie W, Jin X, Sun T, Shang Y, Deng Z, et al. Manganese Ion‐Based NanoPlatforms for Tumor Theranostics. Advanced Healthcare Materials. 2026;15(33). doi:10.1002/adhm.71519
BibTeX
@article{Li2026,
author = {Li, Xiangzhou and Xie, Wenjing and Jin, Xinyu and Sun, Tianrui and Shang, Yingxu and Deng, Zhaojia and Peng, Hanyong},
title = {Manganese Ion‐Based NanoPlatforms for Tumor Theranostics},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {33},
doi = {10.1002/adhm.71519}
}
EUVIMED